Precigen, Inc. Research and Development Expense of Revenue

Research and Development Expense of Revenue of PGEN for past 10 years: annual, quarterly and twelve month trailing (TTM) including Research and Development Expense of Revenue growth rates and interactive chart.


Highlights and Quick Summary

  • Research and Development Expense of Revenue for the quarter ending June 30, 2022 was 410.65% (a 930.49% increase compared to previous quarter)
  • Year-over-year quarterly Research and Development Expense of Revenue increased by 585.33%
  • Annual Research and Development Expense of Revenue for 2021 was 48.27% (a 19.6% increase from previous year)
  • Annual Research and Development Expense of Revenue for 2020 was 40.36% (a -45.07% decrease from previous year)
  • Annual Research and Development Expense of Revenue for 2019 was 73.48% (a -69.67% decrease from previous year)
  • Twelve month Research and Development Expense of Revenue ending June 30, 2022 was 62.76% (a 33.45% increase compared to previous quarter)
  • Twelve month trailing Research and Development Expense of Revenue increased by 29.99% year-over-year
Trailing Research and Development Expense of Revenue for the last four month:
30 Jun '22 31 Mar '22 31 Dec '21 30 Sep '21
62.76% 47.03% 48.27% 48.28%
Visit stockrow.com/PGEN for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Research and Development Expense of Revenue of Precigen, Inc.

Most recent Research and Development Expense of Revenueof PGEN including historical data for past 10 years.

Interactive Chart of Research and Development Expense of Revenue of Precigen, Inc.

Precigen, Inc. Research and Development Expense of Revenue for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 410.65% 39.85%
2021 53.75% 59.92% 40.74% 42.92% 48.27%
2020 55.2% 43.13% 31.14% 37.96% 40.36%
2019 -83.39% 140.26% 86.0% 119.27% 73.48%
2018 617.97% 138.33% 92.87% 93.95% 242.26%
2017 6.91% 79.26% 62.48% 63.59% 62.0%
2016 62.76% 59.27% 54.05% 59.52% 58.73%
2015 63.13% 40.47% 45.4% 234.3% 84.95%
2014 56.73% 70.06% 122.46% 153.53% 82.0%
2013 175.7% 176.63% 201.94% 293.72% 202.62%
2012 491.08% 647.14% 464.89%
2011 876.43%

Business Profile of Precigen, Inc.

Sector: Healthcare
Industry: Biotechnology